(Q36428034)

14 August 2017

1 reference

title

Two different classes of therapy-related and de-novo acute myeloid leukemia? (English)

1 reference

14 August 2017

1 reference

second primary neoplasm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655239

22 October 2022

chromosome abnormality

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655239

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

22 October 2022

author name string

Pedersen-Bjergaard J

1

1 reference

14 August 2017

J. Pedersen-Bjergaard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655239

22 October 2022

P. Philip

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1655239

22 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1655239

22 October 2022

publication date

1 August 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:016546089190246Q?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

https://api.elsevier.com/content/article/PII:016546089190246Q?httpAccept=text/plain

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

Cancer Genetics and Cytogenetics

22 October 2022

published in

1 reference

14 August 2017

volume

55

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

119-124

1 reference

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

14 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

22 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

22 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

DNA topoisomerase poisons as antitumor drugs

22 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

Chromosomes and causation of human cancer and leukemia. L. Cytogenetics of leukemias complicating other diseases

22 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7

22 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

The association of specific "favorable" cytogenetic abnormalities with secondary leukemia

22 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

Favorable cytogenetic abnormalities in secondary leukemia

22 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

Translocation (3;21) in a patient with secondary hematological malignancy

22 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0165-4608(91)90246-Q

22 October 2022

Identifiers

1 reference

14 August 2017

1 reference